1aye: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The three-dimensional structure of human procarboxypeptidase A2 has been, determined using X-ray crystallography at 1.8 A resolution. This is the, first detailed structural report of a human pancreatic carboxypeptidase, and of its zymogen. Human procarboxypeptidase A2 is formed by a, pro-segment of 96 residues, which inhibits the enzyme, and a, carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the, general fold when compared with other non-human counterparts. The globular, part of the pro-segment docks into the enzyme moiety and shields the S2-S4, substrate binding sites, promoting inhibition. Interestingly, important, differences are found in the pro-segment which allow the identification of, the structural determinants of the diverse activation behaviours of, procarboxypeptidases A1, B and A2, particularly of the latter. The, benzylsuccinic inhibitor is able to diffuse into the active site of, procarboxypeptidase A2 in the crystals. The structure of the, zymogen-inhibitor complex has been solved at 2.2 A resolution. The, inhibitor enters the active site through a channel formed at the interface, between the pro-segment and the enzyme regions and interacts with, important elements of the active site. The derived structural features, explain the intrinsic activity of A1/A2 pro-enzymes for small substrates.
The three-dimensional structure of human procarboxypeptidase A2 has been determined using X-ray crystallography at 1.8 A resolution. This is the first detailed structural report of a human pancreatic carboxypeptidase and of its zymogen. Human procarboxypeptidase A2 is formed by a pro-segment of 96 residues, which inhibits the enzyme, and a carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the general fold when compared with other non-human counterparts. The globular part of the pro-segment docks into the enzyme moiety and shields the S2-S4 substrate binding sites, promoting inhibition. Interestingly, important differences are found in the pro-segment which allow the identification of the structural determinants of the diverse activation behaviours of procarboxypeptidases A1, B and A2, particularly of the latter. The benzylsuccinic inhibitor is able to diffuse into the active site of procarboxypeptidase A2 in the crystals. The structure of the zymogen-inhibitor complex has been solved at 2.2 A resolution. The inhibitor enters the active site through a channel formed at the interface between the pro-segment and the enzyme regions and interacts with important elements of the active site. The derived structural features explain the intrinsic activity of A1/A2 pro-enzymes for small substrates.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Aviles, F.X.]]
[[Category: Aviles, F X.]]
[[Category: Coll, M.]]
[[Category: Coll, M.]]
[[Category: Garcia-Saez, I.]]
[[Category: Garcia-Saez, I.]]
Line 24: Line 24:
[[Category: zymogen]]
[[Category: zymogen]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:32:06 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:49:36 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA